FDA Adverse Event Injury Summary report: N

CARPENTIER-EDWARDS® PERIMOUNT MAGNA¿ MITRAL PERICARDIAL BIOPROSTHESIS

MDR report key: 6073795 · Received November 2, 2016

Report

Report Number
2015691-2016-03243
Event Type
Injury
Date Received
November 2, 2016
Date of Event
February 10, 2009
Report Date
October 3, 2016
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
P860057/S029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL MANUFACTURER NARRATIVE: PRODUCT EVALUATION WAS NOT PERFORMED AS THE DEVICE REMAINS IMPLANTED. THE CLINICAL OBSERVATION WAS UNABLE TO BE CONFIRMED. ATRIOVENTRICULAR CONDUCTION DISTURBANCES AFTER AORTIC VALVE REPLACEMENT (AVR) IS ASSOCIATED WITH MANY PATIENT-RELATED AND PROCEDURAL-RELATED FACTORS. THE MECHANISMS OF THE DEVELOPMENT OF HEART BLOCK AFTER AVR ARE WELL DOCUMENTED AND DESCRIBED IN THE LITERATURE. IT IS ALSO DOCUMENTED THAT PRE-EXISTING HEART BLOCK IS COMMON IN PATIENT UNDERGOING AVR AND WILL DEVELOP POST-OPERATIVE HEART BLOCK, POTENTIALLY REQUIRING A PERMANENT PACEMAKER. ARRHYTHMIAS AND CONDUCTION DISTURBANCES ARE ALSO COMMON AFTER SURGICAL REPAIR OR REPLACEMENT OF THE TRICUSPID AND MITRAL VALVES DUE TO THE PROXIMITY OF THE CONDUCTION PATHWAYS. THIS ADVERSE EVENT IS NOT A MANUFACTURING RELATED ISSUE. A DEFINITIVE ROOT CAUSE COULD NOT BE CONFIRMED. NO FURTHER CORRECTIVE OR PREVENTATIVE ACTIONS ARE REQUIRED AT THIS TIME. EDWARDS WILL CONTINUE TO REVIEW AND MONITOR ALL EVENTS THROUGH THE USE OF EDWARDS QUALITY SYSTEMS.

Description of Event or Problem · 1

EDWARDS RECEIVED INFORMATION THAT A PATIENT DEVELOPED A PERSISTENT BRADYCARDIA NODAL RHYTHM AFTER RECEIVING AN EDWARDS 29MM BIOPROSTHETIC VALVE. A PERMANENT PACEMAKER WAS IMPLANTED TO RESOLVE THE ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
722955 CARPENTIER-EDWARDS® PERIMOUNT MAGNA¿ MITRAL PERICARDIAL BIOPROSTHESIS HEART-VALVE, REPLACEMENT DYE EDWARDS LIFESCIENCES 7000TFX29MM

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention